21 – 30 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies : An up to 10-year follow-up study
(
- Contribution to journal › Article
-
Mark
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals
(
- Contribution to journal › Article
-
Mark
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Stress testing the Centiloid : Precision and variability of PET quantification of amyloid pathology
(
- Contribution to journal › Article
-
Mark
Individualized, cross-validated prediction of future dementia using cognitive assessments in people with mild cognitive symptoms
2024) In Alzheimer's and Dementia(
- Contribution to journal › Article
-
Mark
Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Centiloid recommendations for clinical context-of-use from the AMYPAD consortium
(
- Contribution to journal › Article
-
Mark
Plasma p-tau immunoassays in clinical research for Alzheimer's disease
2024) In Alzheimer's and Dementia(
- Contribution to journal › Scientific review
-
Mark
Use of common cardiovascular disease drugs and risk of dementia : A case–control study in Swedish national register data
2024) In Alzheimer's and Dementia(
- Contribution to journal › Article